consumer healthcare

News

Daiichi exits OTC, with $1.55bn unit sale to Suntory

Daiichi Sankyo has agreed to sell its consumer health unit to food and beverage giant Suntory, following a well-trodden path for big pharma companies.

News

Tylenol maker Kenvue agrees $48.7bn Kimberly-Clark takeover

Facing talc and Tylenol litigation, J&J consumer health spinout Kenvue has agreed to a takeover by consumer goods giant Kimberly-Clark.

News

Zentiva set to change hands in €4.1bn private equity deal

Ex-Sanofi generics company Zentiva is poised for a sale by current owner Advent International to US investment group GTCR, says a media report.

News

IPO plan evaporates as private equity firm buys Stada

Stada has confirmed it isn't going ahead with an IPO, as its two private equity owners have just agreed to sell a majority stake to a third.

News

Stada revives talk of an IPO – if conditions improve

Germany's Stada has said it may make another attempt to seek a public listing in the autumn, after delaying its plans earlier this year.

News

Sanofi in talks to sell stake in consumer health spinout

Rumours that Sanofi was in discussion with private equity groups over the sale of its consumer health business Opella have been confirmed – at least partially.

Daiichi exits OTC, with $1.55bn unit sale to Suntory

Tylenol maker Kenvue agrees $48.7bn Kimberly-Clark takeover

Zentiva set to change hands in €4.1bn private equity deal

IPO plan evaporates as private equity firm buys Stada

Stada revives talk of an IPO – if conditions improve

Sanofi in talks to sell stake in consumer health spinout

UK says it has hit target on commercial trial set-up times

Using AI-driven synthetic personas to take your insights fur...

consumer healthcare

Editor's Picks